EVEREST ORGANICS Financial Statement Analysis
|
||
|
The Revenues of EVEREST ORGANICS have increased by 23.00% YoY .
The Earnings Per Share (EPS) of EVEREST ORGANICS has increased by Positive YoY. |
||
EVEREST ORGANICS Last 5 Annual Financial Results
[BOM: 524790]
| Standalone | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹196 Cr | ₹159 Cr | ₹197 Cr | ₹183 Cr | ₹200 Cr |
| Expenses | ₹176 Cr | ₹152 Cr | ₹186 Cr | ₹182 Cr | ₹194 Cr |
| Operating Profit (Excl OI) | ₹20 Cr | ₹7.19 Cr | ₹11 Cr | ₹0.93 Cr | ₹6.43 Cr |
| Other Income | ₹1.25 Cr | ₹0.72 Cr | ₹0.89 Cr | ₹6.94 Cr | ₹2.21 Cr |
| Interest | ₹6.53 Cr | ₹5.19 Cr | ₹5.47 Cr | ₹3.31 Cr | ₹3.10 Cr |
| Depreciation | ₹6.48 Cr | ₹5.96 Cr | ₹5.80 Cr | ₹4.47 Cr | ₹3.80 Cr |
| Profit Before Tax | ₹8.05 Cr | ₹-3.24 Cr | ₹0.61 Cr | ₹0.09 Cr | ₹1.74 Cr |
| Profit After Tax | ₹5.55 Cr | ₹-1.29 Cr | ₹0.14 Cr | ₹-0.18 Cr | ₹1.14 Cr |
| Earnings Per Share (Rs) | ₹5.71 | ₹-1.33 | ₹0.17 | ₹-0.23 | ₹1.43 |
| PAT Margin (%) | 2.46 | -0.71 | 0.06 | -0.09 | 0.50 |
| ROE(%) | 7.68 | -2.25 | 0.30 | -0.39 | 2.45 |
| ROCE(%) | 11.98 | 1.76 | 6.03 | 3.71 | 6.25 |
| Total Debt/Equity(x) | 0.66 | 0.69 | 1.26 | 1.12 | 0.83 |
Key Financials |
||
| Market Cap | : | ₹ 239.9 Cr |
| Revenue (TTM) | : | ₹ 190.8 Cr |
| Net Profit(TTM) | : | ₹ 5.3 Cr |
| EPS (TTM) | : | ₹ 5.3 |
| P/E (TTM) | : | 45.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| EVEREST ORGANICS | -0.7% | 1.7% | -42% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.7% | -0.3% | 3.2% |
| DIVIS LABORATORIES | 4% | 8.9% | 54.1% |
| TORRENT PHARMACEUTICALS | 3.6% | -0.5% | 28.8% |
| CIPLA | 3.2% | 5% | -11.9% |
| DR REDDYS LABORATORIES | 2.5% | 13.6% | 9.4% |
| MANKIND PHARMA | 2.9% | 2.2% | 1.3% |
| LUPIN | 0.9% | 0.3% | 2.8% |
| ZYDUS LIFESCIENCES | 0.3% | 4.5% | 23.7% |
EVEREST ORGANICS Revenues
[BOM: 524790]
| Y-o-Y | 23.00 % |
| 5 Yr CAGR | -0.49 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹196 Cr | 23.00 | |
| Mar2025 | ₹159 Cr | -19.15 | |
| Mar2024 | ₹197 Cr | 7.75 | |
| Mar2023 | ₹183 Cr | -8.50 | |
| Mar2022 | ₹200 Cr | - | |
EVEREST ORGANICS Operating Profit
[BOM: 524790]
| Y-o-Y | 175.54 % |
| 5 Yr CAGR | 32.50 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹20 Cr | 175.54 | |
| Mar2025 | ₹7.19 Cr | -34.56 | |
| Mar2024 | ₹11 Cr | 1,081.40 | |
| Mar2023 | ₹0.93 Cr | -85.53 | |
| Mar2022 | ₹6.43 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 123.95 % |
| 5 Yr CAGR | 33.18 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 10.1% | 123.95 | |
| Mar2025 | 4.51% | -19.03 | |
| Mar2024 | 5.57% | 992.16 | |
| Mar2023 | 0.51% | -84.11 | |
| Mar2022 | 3.21% | - | |
EVEREST ORGANICS Profit After Tax
[BOM: 524790]
| Y-o-Y | Positive |
| 5 Yr CAGR | 48.39 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.55 Cr | Positive | |
| Mar2025 | ₹-1.29 Cr | Negative | |
| Mar2024 | ₹0.14 Cr | Positive | |
| Mar2023 | ₹-0.18 Cr | Negative | |
| Mar2022 | ₹1.14 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Positive |
| 5 Yr CAGR | 48.93 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 2.46 % | Positive | |
| Mar2025 | -0.71 % | Negative | |
| Mar2024 | 0.06 % | Positive | |
| Mar2023 | -0.09 % | Negative | |
| Mar2022 | 0.5 % | - | |
EVEREST ORGANICS Earnings Per Share (EPS)
[BOM: 524790]
| Y-o-Y | Positive |
| 5 Yr CAGR | 41.36 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.71 | Positive | |
| Mar2025 | ₹-1.33 | Negative | |
| Mar2024 | ₹0.17 | Positive | |
| Mar2023 | ₹-0.23 | Negative | |
| Mar2022 | ₹1.43 | - | |
EVEREST ORGANICS Return on Capital Employed (ROCE)
[BOM: 524790]
| Y-o-Y | 580.68 % |
| 5 Yr CAGR | 17.66 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 11.98% | 580.68 | |
| Mar2025 | 1.76% | -70.81 | |
| Mar2024 | 6.03% | 62.53 | |
| Mar2023 | 3.71% | -40.64 | |
| Mar2022 | 6.25% | - | |
EVEREST ORGANICS Share Price vs Sensex
| Current Share Price | : | ₹239.9 |
| Current MarketCap | : | ₹ 239.9 Cr |
| Updated EOD on | : | Nov 04,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -0.7% |
1.7% |
-42% |
| SENSEX | 5.5% |
7.5% |
-8.7% |
EVEREST ORGANICS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about EVEREST ORGANICS Financials
How the annual revenues of EVEREST ORGANICS have changed ?
The Revenues of EVEREST ORGANICS have increased by 23.00% YoY .
How the Earnings per Share (EPS) of EVEREST ORGANICS have changed?
The Earnings Per Share (EPS) of EVEREST ORGANICS has increased by Positive YoY .
Check out Intrinsic Value of Peers of EVEREST ORGANICS
Compare Stock Analytics of Peers of EVEREST ORGANICS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
